MCAT topics → Nervous and Endocrine Systems → Neurotransmitters and Their Receptors

Neurotransmitters and Their Receptors

MCAT trap: Incorrectly assigns ACh as the sympathetic postganglionic neurotransmitter at target organs instead of NE. Sympathetic postganglionic neurons release norepinephrine onto target organs; ACh is released at all autonomic ganglia and at parasympathetic postganglionic terminals.

Neurotransmitters and their receptors is one of the highest-yield topics on the MCAT — tested from pure recall to passage application to psychology connections. The most reliable error: assigning ACh to sympathetic postganglionic terminals. ACh is released at every autonomic ganglion and at all parasympathetic postganglionic synapses. At sympathetic target organs, the transmitter is norepinephrine. Mess this up and every drug-mechanism question about adrenergic vs. cholinergic pharmacology becomes a coin flip.

The tricky part is that neurotransmitters don't have fixed identities — context determines function. ACh can be excitatory or inhibitory depending on receptor subtype and location. GABA is inhibitory in adults but can actually be excitatory during fetal development. Dopamine plays completely opposite roles depending on which pathway you're talking about. Students who memorize a single function per neurotransmitter get burned on application questions. You need to know the NT, its receptor(s), the receptor mechanism, and the physiological or behavioral outcome.

The other major trap is the autonomic nervous system wiring for ACh vs. NE. Many students incorrectly assign ACh to sympathetic postganglionic terminals — a mistake that flips the entire autonomic pharmacology logic. Internalize the rule: ACh is released at ALL autonomic ganglia and all parasympathetic postganglionic synapses; NE is the sympathetic postganglionic transmitter at target organs. Get that straight before anything else.

Common misconceptions

Common mistake
Wrong: ACh is released at sympathetic postganglionic terminals onto target organs.
Right: Sympathetic postganglionic neurons release norepinephrine onto target organs; ACh is released at all autonomic ganglia and at parasympathetic postganglionic terminals.
ACh is released at every autonomic ganglion (both sympathetic and parasympathetic) and at parasympathetic postganglionic terminals — but the sympathetic postganglionic neuron switches to norepinephrine when it synapses onto the target organ. Think of it this way: the ganglion always speaks ACh, but after the synapse, the sympathetic arm hands off to NE for target-organ communication. Mixing these up breaks your entire understanding of adrenergic vs. cholinergic pharmacology.
Common mistake
Wrong: Metabotropic receptors produce faster postsynaptic responses than ionotropic receptors because they amplify the signal.
Right: Ionotropic receptors produce faster responses (milliseconds) by directly gating ion channels; metabotropic receptors are slower (seconds) but produce amplified, prolonged effects via second messengers.
Signal amplification and speed are different things — metabotropic receptors amplify a signal by activating second-messenger cascades, but those extra steps take time (seconds), making them slower. Ionotropic receptors are fast precisely because there are no extra steps: ligand binds, channel opens, ions flow in milliseconds. For the MCAT, 'ionotropic = fast and direct' and 'metabotropic = slow, amplified, and prolonged' is the clean rule.
Common mistake
Wrong: GABA is an excitatory neurotransmitter in the adult brain.
Right: GABA is the primary inhibitory neurotransmitter in the adult CNS, typically opening Cl- channels to hyperpolarize the postsynaptic cell.
GABA is the primary inhibitory neurotransmitter in the adult CNS — it opens Cl⁻ channels (via GABA-A, an ionotropic receptor), driving the membrane potential toward the negative chloride equilibrium potential and hyperpolarizing the cell. The confusion sometimes arises because GABA can be depolarizing early in development, when intracellular Cl⁻ concentrations are higher. On the MCAT, assume adult CNS unless the passage specifies otherwise: GABA = inhibitory.
Common mistake
Gap: Misses the dual role of dopamine dysregulation in both schizophrenia (excess) and Parkinson's disease (deficit)
Excess dopaminergic activity is associated with schizophrenia (positive symptoms), while dopamine deficiency in the nigrostriatal pathway underlies Parkinson's disease.
Dopamine doesn't just do one thing — its role depends entirely on the pathway. In the mesolimbic pathway, excess dopamine activity is linked to the positive symptoms of schizophrenia (hallucinations, delusions), which is why antipsychotics are often dopamine D2 antagonists. In the nigrostriatal pathway, dopaminergic neuron degeneration causes the motor deficits of Parkinson's disease (rigidity, tremor, bradykinesia). Knowing both sides of this — excess and deficit, different pathways, different diseases — is exactly what the MCAT rewards.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the major neurotransmitters by name and category: ACh, glutamate, GABA, glycine, dopamine, serotonin, norepinephrine, and neuropeptides — including where each is primarily found and released.
  2. Distinguish ionotropic receptors (ligand-gated ion channels, millisecond responses) from metabotropic receptors (GPCR-coupled, second-messenger cascades, slower but amplified and prolonged effects) and predict which produces a faster vs. longer-lasting response.
  3. Given a passage describing behavior, cognition, mood, or a drug's mechanism, identify which neurotransmitter system is involved and predict the outcome of increasing or decreasing its activity.
  4. Connect specific neurotransmitter imbalances to psychiatric and neurological conditions — especially dopamine (excess → schizophrenia positive symptoms; nigrostriatal deficit → Parkinson's), serotonin (depression, anxiety), GABA (anxiety, epilepsy), and NE (arousal, ADHD, depression).

Can you avoid these mistakes?

A patient is given a drug that selectively blocks nicotinic ACh receptors at autonomic ganglia. Predict what happens to both sympathetic and parasympathetic signaling to target organs, and explain your reasoning.
A passage describes a receptor that, when activated, leads to a prolonged increase in intracellular cAMP and a slow change in neuronal excitability. Is this receptor ionotropic or metabotropic? How do you know, and what structural feature distinguishes it from the other type?
A researcher finds that a new compound increases GABA activity in the brain. Predict at least two physiological or behavioral effects and name one clinical condition this type of compound is already used to treat.
A patient presents with motor tremors and rigidity. A separate patient presents with auditory hallucinations and paranoid delusions. Both conditions involve dopamine dysregulation — explain how the same neurotransmitter can be implicated in both, and what the difference in mechanism is.

Related topics

Chemical and Electrical Synaptic Transmission Neuron Structure (Dendrite, Axon, Myelin) Resting Membrane Potential and Ion Gradients Action Potential (Depolarization, Repolarization, Refractory Periods) Saltatory Conduction and Conduction Velocity

See how your Anki deck covers this topic.

Upload your deck for a free audit →